Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
ID | DOID:1363 |
Name | ethmoid sinus cancer |
Definition | |
Source | DiseaseOntology.org |
Alt Ids | |
Path | disease disease of cellular proliferation cancer organ system cancer respiratory system cancer paranasal sinus cancer ethmoid sinus cancer |
Molecular Profile | Therapy | Indication/Tumor Type | Response Type | Profile Response Detail |
---|---|---|---|---|
CD274 positive | Pembrolizumab | ethmoid sinus cancer | sensitive | detail... |
CD274 positive | Ipilimumab + Nivolumab | ethmoid sinus cancer | sensitive | detail... |
MLH1 negative | Pembrolizumab | ethmoid sinus cancer | sensitive | detail... |
PMS2 negative | Pembrolizumab | ethmoid sinus cancer | sensitive | detail... |
MSH2 negative | Pembrolizumab | ethmoid sinus cancer | sensitive | detail... |
MSH6 negative | Pembrolizumab | ethmoid sinus cancer | sensitive | detail... |
FGFR1 act mut | Erdafitinib | ethmoid sinus cancer | sensitive | detail... |
FGFR1 fusion | Erdafitinib | ethmoid sinus cancer | sensitive | detail... |
FGFR2 act mut | Erdafitinib | ethmoid sinus cancer | sensitive | detail... |
FGFR2 fusion | Erdafitinib | ethmoid sinus cancer | sensitive | detail... |
FGFR3 act mut | Erdafitinib | ethmoid sinus cancer | sensitive | detail... |
FGFR3 fusion | Erdafitinib | ethmoid sinus cancer | sensitive | detail... |
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|